The −251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population
Purpose: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1β polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The −251A/T polymorphism of the IL-8 promoter is involved in s...
Saved in:
Published in | Clinical cancer research Vol. 11; no. 18; pp. 6431 - 6441 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
American Association for Cancer Research
15.09.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1β
polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The −251A/T polymorphism
of the IL-8 promoter is involved in several human diseases. Particularly, the −251A is associated with decreased risk of colorectal cancer.
We aimed to determine whether the −251 allele resulting in high IL-8 expression was associated with increased risk of gastric
carcinoma.
Experimental Design: The −251A/T promoters were cloned and analyzed by luciferase assay. Binding of nuclear proteins to the −251A/T promoters
was analyzed by electrophoretic mobility shift assay. The −251A/T promoters were differentiated by PCR-RFLP. Comparison of
gastric cancer risk between the −251A/T promoters was done by a case-control study.
Results: The −251T allele possessed transcriptional activity 2- to 5-fold stronger than the −251A counterpart. Electrophoretic mobility
shift assay showed that the −251A promoter had strong ability to bind to an unknown protein or multiprotein complex. The −251T
allele was associated with increased risk of noncardia ( P trend = 0.012) and cardia ( P trend = 0.029) carcinomas. Gastric carcinoma patients with the low-risk AA genotype had a tendency to sustain intestinal-type carcinomas
(χ 2 = 6.816; P = 0.033); however, the high-risk −251T allele was associated with >2-fold increased risk of diffuse-type (AA versus AT +
TT: odds ratio, 2.52; 95% confidence interval, 1.16-5.49; P = 0.017) and mixed-type (AA versus AT + TT: odds ratio, 2.22; 95% confidence interval, 1.12-4.40; P = 0.019) carcinomas.
Conclusions: The IL-8 −251T allele is significantly associated with increased risk of gastric carcinoma, particularly the diffuse and
mixed types in Chinese population. |
---|---|
AbstractList | PURPOSE: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1 beta polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The -251A/T polymorphism of the IL-8 promoter is involved in several human diseases. Particularly, the -251A is associated with decreased risk of colorectal cancer. We aimed to determine whether the -251 allele resulting in high IL-8 expression was associated with increased risk of gastric carcinoma. Experimental Design: The -251A/T promoters were cloned and analyzed by luciferase assay. Binding of nuclear proteins to the -251A/T promoters was analyzed by electrophoretic mobility shift assay. The -251A/T promoters were differentiated by PCR-RFLP. Comparison of gastric cancer risk between the -251A/T promoters was done by a case-control study. RESULTS: The -251T allele possessed transcriptional activity 2- to 5-fold stronger than the -251A counterpart. Electrophoretic mobility shift assay showed that the -251A promoter had strong ability to bind to an unknown protein or multiprotein complex. The -251T allele was associated with increased risk of noncardia (P sub(trend) = 0.012) and cardia (P sub(trend) = 0.029) carcinomas. Gastric carcinoma patients with the low-risk AA genotype had a tendency to sustain intestinal-type carcinomas ( chi super(2) = 6.816; P = 0.033); however, the high-risk -251T allele was associated with >2-fold increased risk of diffuse-type (AA versus AT + TT: odds ratio, 2.52; 95% confidence interval, 1.16-5.49; P = 0.017) and mixed-type (AA versus AT + TT: odds ratio, 2.22; 95% confidence interval, 1.12-4.40; P = 0.019) carcinomas. CONCLUSIONS: The IL-8 -251T allele is significantly associated with increased risk of gastric carcinoma, particularly the diffuse and mixed types in Chinese population. Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1beta polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The -251A/T polymorphism of the IL-8 promoter is involved in several human diseases. Particularly, the -251A is associated with decreased risk of colorectal cancer. We aimed to determine whether the -251 allele resulting in high IL-8 expression was associated with increased risk of gastric carcinoma. The -251A/T promoters were cloned and analyzed by luciferase assay. Binding of nuclear proteins to the -251A/T promoters was analyzed by electrophoretic mobility shift assay. The -251A/T promoters were differentiated by PCR-RFLP. Comparison of gastric cancer risk between the -251A/T promoters was done by a case-control study. The -251T allele possessed transcriptional activity 2- to 5-fold stronger than the -251A counterpart. Electrophoretic mobility shift assay showed that the -251A promoter had strong ability to bind to an unknown protein or multiprotein complex. The -251T allele was associated with increased risk of noncardia (P(trend) = 0.012) and cardia (P(trend) = 0.029) carcinomas. Gastric carcinoma patients with the low-risk AA genotype had a tendency to sustain intestinal-type carcinomas (chi(2) = 6.816; P = 0.033); however, the high-risk -251T allele was associated with >2-fold increased risk of diffuse-type (AA versus AT + TT: odds ratio, 2.52; 95% confidence interval, 1.16-5.49; P = 0.017) and mixed-type (AA versus AT + TT: odds ratio, 2.22; 95% confidence interval, 1.12-4.40; P = 0.019) carcinomas. The IL-8 -251T allele is significantly associated with increased risk of gastric carcinoma, particularly the diffuse and mixed types in Chinese population. Purpose: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1β polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The −251A/T polymorphism of the IL-8 promoter is involved in several human diseases. Particularly, the −251A is associated with decreased risk of colorectal cancer. We aimed to determine whether the −251 allele resulting in high IL-8 expression was associated with increased risk of gastric carcinoma. Experimental Design: The −251A/T promoters were cloned and analyzed by luciferase assay. Binding of nuclear proteins to the −251A/T promoters was analyzed by electrophoretic mobility shift assay. The −251A/T promoters were differentiated by PCR-RFLP. Comparison of gastric cancer risk between the −251A/T promoters was done by a case-control study. Results: The −251T allele possessed transcriptional activity 2- to 5-fold stronger than the −251A counterpart. Electrophoretic mobility shift assay showed that the −251A promoter had strong ability to bind to an unknown protein or multiprotein complex. The −251T allele was associated with increased risk of noncardia ( P trend = 0.012) and cardia ( P trend = 0.029) carcinomas. Gastric carcinoma patients with the low-risk AA genotype had a tendency to sustain intestinal-type carcinomas (χ 2 = 6.816; P = 0.033); however, the high-risk −251T allele was associated with >2-fold increased risk of diffuse-type (AA versus AT + TT: odds ratio, 2.52; 95% confidence interval, 1.16-5.49; P = 0.017) and mixed-type (AA versus AT + TT: odds ratio, 2.22; 95% confidence interval, 1.12-4.40; P = 0.019) carcinomas. Conclusions: The IL-8 −251T allele is significantly associated with increased risk of gastric carcinoma, particularly the diffuse and mixed types in Chinese population. Abstract Purpose: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1β polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The −251A/T polymorphism of the IL-8 promoter is involved in several human diseases. Particularly, the −251A is associated with decreased risk of colorectal cancer. We aimed to determine whether the −251 allele resulting in high IL-8 expression was associated with increased risk of gastric carcinoma. Experimental Design: The −251A/T promoters were cloned and analyzed by luciferase assay. Binding of nuclear proteins to the −251A/T promoters was analyzed by electrophoretic mobility shift assay. The −251A/T promoters were differentiated by PCR-RFLP. Comparison of gastric cancer risk between the −251A/T promoters was done by a case-control study. Results: The −251T allele possessed transcriptional activity 2- to 5-fold stronger than the −251A counterpart. Electrophoretic mobility shift assay showed that the −251A promoter had strong ability to bind to an unknown protein or multiprotein complex. The −251T allele was associated with increased risk of noncardia (Ptrend = 0.012) and cardia (Ptrend = 0.029) carcinomas. Gastric carcinoma patients with the low-risk AA genotype had a tendency to sustain intestinal-type carcinomas (χ2 = 6.816; P = 0.033); however, the high-risk −251T allele was associated with >2-fold increased risk of diffuse-type (AA versus AT + TT: odds ratio, 2.52; 95% confidence interval, 1.16-5.49; P = 0.017) and mixed-type (AA versus AT + TT: odds ratio, 2.22; 95% confidence interval, 1.12-4.40; P = 0.019) carcinomas. Conclusions: The IL-8 −251T allele is significantly associated with increased risk of gastric carcinoma, particularly the diffuse and mixed types in Chinese population. PURPOSEPersistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1beta polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The -251A/T polymorphism of the IL-8 promoter is involved in several human diseases. Particularly, the -251A is associated with decreased risk of colorectal cancer. We aimed to determine whether the -251 allele resulting in high IL-8 expression was associated with increased risk of gastric carcinoma.EXPERIMENTAL DESIGNThe -251A/T promoters were cloned and analyzed by luciferase assay. Binding of nuclear proteins to the -251A/T promoters was analyzed by electrophoretic mobility shift assay. The -251A/T promoters were differentiated by PCR-RFLP. Comparison of gastric cancer risk between the -251A/T promoters was done by a case-control study.RESULTSThe -251T allele possessed transcriptional activity 2- to 5-fold stronger than the -251A counterpart. Electrophoretic mobility shift assay showed that the -251A promoter had strong ability to bind to an unknown protein or multiprotein complex. The -251T allele was associated with increased risk of noncardia (P(trend) = 0.012) and cardia (P(trend) = 0.029) carcinomas. Gastric carcinoma patients with the low-risk AA genotype had a tendency to sustain intestinal-type carcinomas (chi(2) = 6.816; P = 0.033); however, the high-risk -251T allele was associated with >2-fold increased risk of diffuse-type (AA versus AT + TT: odds ratio, 2.52; 95% confidence interval, 1.16-5.49; P = 0.017) and mixed-type (AA versus AT + TT: odds ratio, 2.22; 95% confidence interval, 1.12-4.40; P = 0.019) carcinomas.CONCLUSIONSThe IL-8 -251T allele is significantly associated with increased risk of gastric carcinoma, particularly the diffuse and mixed types in Chinese population. |
Author | Yee Chao Anna Fen-Yau Li Chung-Pin Li Meei-Ling Sheu Yi-Ping Lin Shang-Heu Yen Dar-In Tai Wei-Ping Lee En-Ju Lin Full-Young Chang Hou-Ching Hsu Shou-Dong Lee Keng-Hsin Lan |
Author_xml | – sequence: 1 givenname: Wei-Ping surname: LEE fullname: LEE, Wei-Ping organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China – sequence: 2 givenname: Dar-In surname: TAI fullname: TAI, Dar-In organization: The Liver Research Unit, Department of Gastroenterolooy and Hcpatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China – sequence: 3 givenname: Yee surname: CHAO fullname: CHAO, Yee organization: School of Mediciine, National Yang Ming University, Taiwan, Province of China – sequence: 4 givenname: Shang-Heu surname: YEN fullname: YEN, Shang-Heu organization: School of Mediciine, National Yang Ming University, Taiwan, Province of China – sequence: 5 givenname: Shou-Dong surname: LEE fullname: LEE, Shou-Dong organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China – sequence: 6 givenname: Keng-Hsin surname: LAN fullname: LAN, Keng-Hsin organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China – sequence: 7 givenname: Anna Fen-Yau surname: LI fullname: LI, Anna Fen-Yau organization: Department of Pathology, Taipei Veterans General Hospital, Taiwan, Province of China – sequence: 8 givenname: Hou-Ching surname: HSU fullname: HSU, Hou-Ching organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China – sequence: 9 givenname: En-Ju surname: LIN fullname: LIN, En-Ju organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China – sequence: 10 givenname: Yi-Ping surname: LIN fullname: LIN, Yi-Ping organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China – sequence: 11 givenname: Meei-Ling surname: SHEU fullname: SHEU, Meei-Ling organization: Department of Toxicology, National Taiwan University College of Medicine, Taipei, Taiwan, Province of China – sequence: 12 givenname: Chung-Pin surname: LI fullname: LI, Chung-Pin organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China – sequence: 13 givenname: Full-Young surname: CHANG fullname: CHANG, Full-Young organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17118274$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16166417$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkcFuFCEYx4mpse3qI2i4aOJhKswAwx43o203aWLTrGfCsN_sYGdhBCbNvoFnX8E380lksmt69AR8-f2B_H-X6Mx5Bwi9peSKUi4_UVLLgrCqvGqah4LwgixZ-QJdUM7roioFP8v7f8w5uozxOyGUUcJeoXMqqBCM1hfo96YH_Ofnr5LTDV4NAwyAfYdTnq5dgjDA9GhdIfF98HufB3gd8SpGb6xOsMVPNvWZNAF0zMcHGx_n_I2OKViDGx2MdX6v8TXoNAXrdviz7bopQrE5jIBvbUx-1Kn3g98dsHW46a2DCPjej9Ogk_XuNXrZ6SHCm9O6QN-uv2ya2-Lu6826Wd0VhpEyFZ2RLalZJUzFRc1M29ZGLEuzZKztjJGlbPUWOkbokjJDclHSsGpLasO5qISsFujD8d4x-B8TxKT2NhoYBu3AT1EJyaVktPovSOvcLV2SDPIjaIKPMUCnxmD3OhwUJWrWqGZFalakskZFuJo15ty70wNTu4ftc-rkLQPvT4CORg9d0M7Y-MzVlMoyd7FAH49cb3f9kw2gTCYhhNxwVtPnTygqlWAVrf4CThq3Sg |
CitedBy_id | crossref_primary_10_2217_17410541_5_6_589 crossref_primary_10_1111_j_1751_2980_2009_00380_x crossref_primary_10_1016_j_dld_2008_02_031 crossref_primary_10_1016_j_humimm_2006_03_018 crossref_primary_10_1042_BJ20071341 crossref_primary_10_1093_annonc_mdn368 crossref_primary_10_1093_annonc_mdn400 crossref_primary_10_1093_aje_kwq370 crossref_primary_10_1586_17474124_2_4_577 crossref_primary_10_1155_2018_3148137 crossref_primary_10_1016_j_taap_2013_05_019 crossref_primary_10_1177_1010428317705747 crossref_primary_10_3748_wjg_14_5744 crossref_primary_10_1038_nrc2069 crossref_primary_10_1016_j_psychres_2020_113421 crossref_primary_10_1002_path_5214 crossref_primary_10_1189_jlb_4BT0214_100R crossref_primary_10_1371_journal_pone_0104436 crossref_primary_10_3109_03009742_2012_726372 crossref_primary_10_1016_j_humimm_2007_06_006 crossref_primary_10_1111_j_1744_313X_2012_01096_x crossref_primary_10_1016_j_cyto_2022_155806 crossref_primary_10_1016_j_cyto_2012_06_239 crossref_primary_10_1111_j_1365_2249_2007_03489_x crossref_primary_10_1111_j_1365_2591_2012_02097_x crossref_primary_10_1089_dna_2011_1438 crossref_primary_10_1007_s11060_015_2005_9 crossref_primary_10_1097_IAE_0b013e318285cf92 crossref_primary_10_1186_1471_2407_8_326 crossref_primary_10_3892_mco_2016_1044 crossref_primary_10_1111_j_1440_1746_2008_05314_x crossref_primary_10_1016_j_humimm_2013_06_033 crossref_primary_10_1371_journal_pone_0090945 crossref_primary_10_1007_s00408_017_0058_6 crossref_primary_10_1007_s11033_011_1042_5 crossref_primary_10_1186_s43042_022_00348_z crossref_primary_10_1017_S0950268809990677 crossref_primary_10_1016_j_bpg_2007_02_002 crossref_primary_10_2217_fon_10_13 crossref_primary_10_1111_j_1469_0691_2009_03031_x crossref_primary_10_1016_j_cyto_2017_06_001 crossref_primary_10_1111_j_1440_1746_2009_06188_x crossref_primary_10_1007_s11596_011_0161_5 crossref_primary_10_1111_hel_12297 crossref_primary_10_3390_ijms19103214 crossref_primary_10_1111_j_1440_1827_2010_02567_x crossref_primary_10_1097_MCG_0b013e318178d1d3 crossref_primary_10_1016_j_yexmp_2017_07_004 crossref_primary_10_1186_1465_9921_12_73 crossref_primary_10_25048_tudod_1198053 crossref_primary_10_1007_s13277_015_3593_x crossref_primary_10_1016_j_ejca_2010_03_011 crossref_primary_10_1038_onc_2010_352 crossref_primary_10_1016_j_cyto_2021_155489 crossref_primary_10_3945_jn_108_101865 crossref_primary_10_1080_21655979_2021_1933680 crossref_primary_10_1016_j_genrep_2022_101500 crossref_primary_10_1177_145749690609500402 crossref_primary_10_1186_s41043_021_00280_9 crossref_primary_10_1016_j_clim_2007_07_010 crossref_primary_10_1007_s10620_009_0978_y crossref_primary_10_3390_biomedicines12020321 crossref_primary_10_1517_14728222_2012_677440 crossref_primary_10_1111_j_1440_1746_2010_06310_x crossref_primary_10_1111_j_1601_0825_2011_01882_x crossref_primary_10_1016_j_meegid_2011_02_014 crossref_primary_10_1007_s13277_014_1881_5 crossref_primary_10_1016_j_intimp_2019_106026 crossref_primary_10_1002_mc_20661 crossref_primary_10_1016_j_jcmgh_2017_03_005 crossref_primary_10_1186_1471_2407_7_70 crossref_primary_10_1016_j_jcmgh_2022_01_022 crossref_primary_10_1089_jir_2009_0007 crossref_primary_10_1016_j_cyto_2017_07_006 crossref_primary_10_1016_j_mrfmmm_2008_06_006 crossref_primary_10_7314_APJCP_2014_15_7_2951 crossref_primary_10_1111_j_1365_2036_2007_03268_x crossref_primary_10_1016_j_ophtha_2010_10_014 crossref_primary_10_29058_mjwbs_1339421 crossref_primary_10_1089_dna_2012_1692 crossref_primary_10_1038_bjc_2012_177 crossref_primary_10_1099_jmm_0_058073_0 crossref_primary_10_1016_j_amjms_2021_01_017 crossref_primary_10_1371_journal_pone_0028083 crossref_primary_10_1097_CEJ_0b013e32809b4d0f crossref_primary_10_1007_s10753_009_9160_0 crossref_primary_10_1007_s11033_013_2993_5 crossref_primary_10_1111_acps_12339 crossref_primary_10_7314_APJCP_2013_14_7_4403 crossref_primary_10_1016_j_bpg_2006_04_006 crossref_primary_10_1016_j_cyto_2013_11_001 crossref_primary_10_1007_s10552_007_0129_8 crossref_primary_10_1172_JCI30111 crossref_primary_10_1186_s12885_017_3378_2 crossref_primary_10_3109_08916934_2015_1134507 crossref_primary_10_1007_s10528_015_9704_y crossref_primary_10_1016_j_bbcan_2010_01_007 crossref_primary_10_1016_j_hoc_2010_06_007 crossref_primary_10_1053_j_gastro_2007_11_009 crossref_primary_10_7704_kjhugr_2016_16_2_73 crossref_primary_10_1016_j_canlet_2010_04_025 crossref_primary_10_1016_j_ctrv_2013_02_004 crossref_primary_10_1111_j_1523_5378_2007_00575_x crossref_primary_10_1097_MCG_0b013e3181646701 crossref_primary_10_1002_ijc_21979 crossref_primary_10_1016_j_cca_2006_08_023 crossref_primary_10_1155_2009_212345 crossref_primary_10_1002_jso_22037 crossref_primary_10_1111_tmi_12787 crossref_primary_10_1093_annonc_mdp280 crossref_primary_10_1111_cei_12592 crossref_primary_10_1016_j_ejca_2009_03_017 |
Cites_doi | 10.4049/jimmunol.170.6.3369 10.1111/j.1365-2249.2003.02305.x 10.1053/gast.1996.v110.pm8964399 10.1074/jbc.M305536200 10.1056/NEJMoa001999 10.1053/gast.2002.37043 10.1111/j.1365-2362.1992.tb01480.x 10.1172/JCI114265 10.1056/NEJM199110173251603 10.1016/S0959-8049(01)00147-2 10.3109/07853899809002488 10.1078/0344-0338-00038 10.1002/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K 10.1056/NEJMra020542 10.1053/gast.2001.28000 10.1042/bj3480473 10.1136/jcp.47.4.318 10.1016/j.humimm.2004.01.015 10.1016/j.jaci.2004.06.038 10.1126/science.1281554 10.1053/gast.2002.34781 10.1016/1043-4666(89)91043-0 10.1111/apm.1965.64.1.31 10.1016/S0016-5085(03)00899-0 10.1111/j.1365-2249.1995.tb05549.x 10.1097/00002030-200405210-00016 10.1046/j.1523-5378.2003.00130.x 10.1046/j.1365-3083.1998.00300.x 10.1007/BF03257159 10.1016/S0016-5085(03)00157-4 10.1002/1529-0131(200101)44:1<31::AID-ANR5>3.0.CO;2-4 10.1038/sj.gene.6364067 10.1038/35006081 10.1016/S0954-6111(98)90118-4 10.1038/sj.bjc.6690742 10.4049/jimmunol.160.5.2401 10.1074/jbc.M207418200 10.1136/thorax.55.12.1023 10.1111/j.1365-2559.1987.tb01863.x 10.1002/ijc.11724 |
ContentType | Journal Article |
Copyright | 2005 INIST-CNRS |
Copyright_xml | – notice: 2005 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TO H94 7X8 |
DOI | 10.1158/1078-0432.CCR-05-0942 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | Oncogenes and Growth Factors Abstracts MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1557-3265 |
EndPage | 6441 |
ExternalDocumentID | 10_1158_1078_0432_CCR_05_0942 16166417 17118274 11_18_6431 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GeographicLocations | Asia China |
GeographicLocations_xml | – name: China |
GroupedDBID | - 08R 29B 2WC 34G 39C 3O- 53G 55 5GY 5RE 5VS AAPBV ABFLS ABOCM ACIWK ACPRK ADACO ADBBV ADBIT AENEX AETEA AFFNX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL C1A CS3 DIK DU5 E3Z EBS EJD F5P FH7 FRP GJ GX1 H13 H~9 IH2 KQ8 L7B LSO MVM O0- OHT OK1 P0W P2P RCR RHF RHI RNS SJN UDS VH1 W2D WOQ X7M XFK XJT ZA5 ZCG ZGI --- .55 .GJ 18M 1CY 2FS 476 4H- 6J9 AAUGY ACGFO ACSVP ADCOW ADNWM AFHIN AFOSN AI. BR6 BTFSW IQODW J5H QTD TR2 W8F WHG YKV CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TO H94 7X8 |
ID | FETCH-LOGICAL-c402t-fc8b07436c35674cbb7c692c944bfcc828badef401914c01558c43d07c5563683 |
ISSN | 1078-0432 |
IngestDate | Sun Sep 29 07:16:07 EDT 2024 Sun Sep 29 08:40:35 EDT 2024 Thu Sep 26 15:52:03 EDT 2024 Sat Sep 28 07:51:08 EDT 2024 Sun Oct 29 17:07:56 EDT 2023 Fri Jan 15 20:06:56 EST 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 18 |
Keywords | Human Angiogenic factor Transcription promoter Cytokine Risk Malignant tumor Epidemiology Stomach carcinoma Allele Anatomic pathology Histopathology Risk factor Digestive diseases Chinese Genetics Interleukin 8 Gastric disease |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c402t-fc8b07436c35674cbb7c692c944bfcc828badef401914c01558c43d07c5563683 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 16166417 |
PQID | 17417190 |
PQPubID | 23462 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_68588413 proquest_miscellaneous_17417190 crossref_primary_10_1158_1078_0432_CCR_05_0942 pubmed_primary_16166417 pascalfrancis_primary_17118274 highwire_cancerresearch_11_18_6431 |
ProviderPackageCode | RHF RHI |
PublicationCentury | 2000 |
PublicationDate | 2005-09-15 |
PublicationDateYYYYMMDD | 2005-09-15 |
PublicationDate_xml | – month: 09 year: 2005 text: 2005-09-15 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | Philadelphia, PA |
PublicationPlace_xml | – name: Philadelphia, PA – name: United States |
PublicationTitle | Clinical cancer research |
PublicationTitleAlternate | Clin Cancer Res |
PublicationYear | 2005 |
Publisher | American Association for Cancer Research |
Publisher_xml | – name: American Association for Cancer Research |
References | 2022061104165998600_B39 2022061104165998600_B38 2022061104165998600_B37 2022061104165998600_B36 2022061104165998600_B35 2022061104165998600_B34 2022061104165998600_B33 2022061104165998600_B32 2022061104165998600_B31 2022061104165998600_B30 2022061104165998600_B49 2022061104165998600_B48 2022061104165998600_B47 2022061104165998600_B46 2022061104165998600_B45 2022061104165998600_B44 2022061104165998600_B43 2022061104165998600_B42 2022061104165998600_B41 2022061104165998600_B40 2022061104165998600_B19 2022061104165998600_B18 2022061104165998600_B17 2022061104165998600_B16 2022061104165998600_B15 2022061104165998600_B14 2022061104165998600_B13 2022061104165998600_B12 2022061104165998600_B11 2022061104165998600_B10 2022061104165998600_B6 2022061104165998600_B5 2022061104165998600_B8 2022061104165998600_B7 2022061104165998600_B2 2022061104165998600_B1 2022061104165998600_B4 2022061104165998600_B3 2022061104165998600_B29 2022061104165998600_B28 2022061104165998600_B27 2022061104165998600_B26 2022061104165998600_B25 2022061104165998600_B24 2022061104165998600_B23 2022061104165998600_B22 2022061104165998600_B21 2022061104165998600_B20 2022061104165998600_B9 |
References_xml | – ident: 2022061104165998600_B16 doi: 10.4049/jimmunol.170.6.3369 – ident: 2022061104165998600_B26 doi: 10.1111/j.1365-2249.2003.02305.x – ident: 2022061104165998600_B4 doi: 10.1053/gast.1996.v110.pm8964399 – ident: 2022061104165998600_B34 doi: 10.1074/jbc.M305536200 – ident: 2022061104165998600_B2 doi: 10.1056/NEJMoa001999 – ident: 2022061104165998600_B5 doi: 10.1053/gast.2002.37043 – ident: 2022061104165998600_B43 doi: 10.1111/j.1365-2362.1992.tb01480.x – ident: 2022061104165998600_B36 – ident: 2022061104165998600_B11 doi: 10.1172/JCI114265 – ident: 2022061104165998600_B1 doi: 10.1056/NEJM199110173251603 – ident: 2022061104165998600_B22 doi: 10.1016/S0959-8049(01)00147-2 – ident: 2022061104165998600_B46 doi: 10.3109/07853899809002488 – ident: 2022061104165998600_B42 doi: 10.1078/0344-0338-00038 – ident: 2022061104165998600_B48 – ident: 2022061104165998600_B44 doi: 10.1002/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K – ident: 2022061104165998600_B3 doi: 10.1056/NEJMra020542 – ident: 2022061104165998600_B7 doi: 10.1053/gast.2001.28000 – ident: 2022061104165998600_B35 doi: 10.1042/bj3480473 – ident: 2022061104165998600_B18 – ident: 2022061104165998600_B24 – ident: 2022061104165998600_B37 doi: 10.1136/jcp.47.4.318 – ident: 2022061104165998600_B32 doi: 10.1016/j.humimm.2004.01.015 – ident: 2022061104165998600_B28 doi: 10.1016/j.jaci.2004.06.038 – ident: 2022061104165998600_B17 doi: 10.1126/science.1281554 – ident: 2022061104165998600_B12 doi: 10.1053/gast.2002.34781 – ident: 2022061104165998600_B10 doi: 10.1016/1043-4666(89)91043-0 – ident: 2022061104165998600_B41 doi: 10.1111/apm.1965.64.1.31 – ident: 2022061104165998600_B8 doi: 10.1016/S0016-5085(03)00899-0 – ident: 2022061104165998600_B15 – ident: 2022061104165998600_B47 doi: 10.1111/j.1365-2249.1995.tb05549.x – ident: 2022061104165998600_B31 doi: 10.1097/00002030-200405210-00016 – ident: 2022061104165998600_B33 doi: 10.1046/j.1523-5378.2003.00130.x – ident: 2022061104165998600_B45 doi: 10.1046/j.1365-3083.1998.00300.x – ident: 2022061104165998600_B38 – ident: 2022061104165998600_B49 doi: 10.1007/BF03257159 – ident: 2022061104165998600_B9 doi: 10.1016/S0016-5085(03)00157-4 – ident: 2022061104165998600_B20 doi: 10.1002/1529-0131(200101)44:1<31::AID-ANR5>3.0.CO;2-4 – ident: 2022061104165998600_B30 doi: 10.1038/sj.gene.6364067 – ident: 2022061104165998600_B6 doi: 10.1038/35006081 – ident: 2022061104165998600_B19 – ident: 2022061104165998600_B25 – ident: 2022061104165998600_B21 doi: 10.1016/S0954-6111(98)90118-4 – ident: 2022061104165998600_B27 doi: 10.1038/sj.bjc.6690742 – ident: 2022061104165998600_B13 doi: 10.4049/jimmunol.160.5.2401 – ident: 2022061104165998600_B40 doi: 10.1074/jbc.M207418200 – ident: 2022061104165998600_B14 – ident: 2022061104165998600_B29 doi: 10.1136/thorax.55.12.1023 – ident: 2022061104165998600_B39 doi: 10.1111/j.1365-2559.1987.tb01863.x – ident: 2022061104165998600_B23 doi: 10.1002/ijc.11724 |
SSID | ssj0014104 |
Score | 2.271575 |
Snippet | Purpose: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1β
polymorphisms, which enhance... Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1beta polymorphisms, which enhance the... Abstract Purpose: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1β polymorphisms, which... PURPOSE: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1 beta polymorphisms, which... PURPOSEPersistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1beta polymorphisms, which enhance... |
SourceID | proquest crossref pubmed pascalfrancis highwire |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 6431 |
SubjectTerms | Adult Aged Alleles Antineoplastic agents Base Sequence Biological and medical sciences Case-Control Studies Cell Line, Tumor Chi-Square Distribution China Female gastric cancer Gastroenterology. Liver. Pancreas. Abdomen Gene Frequency Genotype Helicobacter Infections - genetics Helicobacter Infections - microbiology Helicobacter pylori Humans Interleukin-8 Interleukin-8 - genetics Male Medical sciences Middle Aged Odds Ratio Pharmacology. Drug treatments polymorphism Polymorphism, Single Nucleotide Promoter Regions, Genetic - genetics Risk Factors Stomach Neoplasms - genetics Stomach Neoplasms - microbiology Stomach Neoplasms - pathology Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Tumor Cells, Cultured Tumors |
Title | The −251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population |
URI | http://clincancerres.aacrjournals.org/content/11/18/6431.abstract https://www.ncbi.nlm.nih.gov/pubmed/16166417 https://search.proquest.com/docview/17417190 https://search.proquest.com/docview/68588413 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiPeWx2IhbpVLHk7iHFG1S0G7C0KtKCcrdp0lYklXTXPh18A_ZSbOU-qKxyWqonh6-L6Mx5NvZgh5pVUgonWSMM9zOeM6TpkS3GWKizUQShnHweLks_NwvuTvV8FqNPrZUy2VOzXVP_bWlfwPqnAPcMUq2X9AtjUKN-A34AtXQBiuf40xg9BhMcGJKJftB3_sAbG9NOW3LGcCJViAh9ni7PKkRqMRnWc5Ro2F6TTmFwlO8tDYslpn-eZ7MkkNNv_ElAJOUykLw6q8bdWpGAca2y5OWD34tZpnOblqh4L1Q99ZU4OpkWjbSd1mqE1H15KgzyZjH5v9tEop1KXwW_aukw_ZtC3sEhdsXmTd_cyKNPNkAkCxL0k5yGoEKMGwdZ21I3aw8y_3h57a7TNS9PwuxFVubw_HIG___hCIKlVRG5_OZp8q9WJsW3wN-3Gff5Any9NTuTheLW6Qmx64MvShb1etiAhFstyqWq3BukYM_ub13j8ZRj9NR2oU5CYFIJDaYSrXn3aqqGdxl9ypjyv0jeXePTIy-X1y66wWZDwgv4CCtKIgtRSkm5QCBemAgrShIM0K2lGQIgVpS0GKFMT1NQVpS0HaUpD2KUiHFARLtKYg7Sj4kCxPjhezOaunfjDNHW_HUi0UxrWh9oMw4lqpSIexp2POVaq18IRK1iblDnYm1BjyC839tRNp7HUXCv8ROcg3uTkkFIJTDTZ8N1AuX3tJHJhQOIrH3E_iMDBjMm3QkFe2uYusDsWBkAifRPgkwCedQCJ8Y_KywUzal6V5V2CRdIVEHo7J0QDNznSEp_mIj8mLBl4Jzhy_0CW52ZQFPMHhodi5_gkcFwG-1B-Tx5YXnfXQDUNY_uSPa5-S290r94wc7LaleQ6h9U4dVez-DZrB0MY |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+-251T+allele+of+the+interleukin-8+promoter+is+associated+with+increased+risk+of+gastric+carcinoma+featuring+diffuse-type+histopathology+in+Chinese+population&rft.jtitle=Clinical+cancer+research&rft.au=Lee%2C+Wei-Ping&rft.au=Tai%2C+Dar-In&rft.au=Lan%2C+Keng-Hsin&rft.au=Li%2C+Anna+Fen-Yau&rft.date=2005-09-15&rft.issn=1078-0432&rft.volume=11&rft.issue=18&rft.spage=6431&rft.epage=6441&rft_id=info:doi/10.1158%2F1078-0432.CCR-05-0942&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-0432&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-0432&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-0432&client=summon |